Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PANW vs GSK✓SelectedUSD · GSKPANW vs GSK performance historyLatest closeAs of-5.09%11/20
Stock and ETF performance explorer

PANW vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+3,777.1%
GSK return
+108.7%
Excess return
+3,668.4%
Maximum drawdown
-48.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.1%-0.1%-5.0%-5.1%
7D+6.5%-5.3%+11.9%+8.0%
30D-1.1%-3.7%+2.5%-0.2%
3M-1.8%-7.3%+5.5%-0.1%
6M+39.2%-4.2%+43.4%+39.6%
YTD+86.4%+0.9%+85.5%+81.9%
1Y+85.5%+7.3%+78.2%+77.3%
3Y+163.5%+52.7%+110.8%+116.7%
5Y+288.4%+40.1%+248.3%+224.2%
10Y+1,176.7%+98.7%+1,078.0%+768.2%
All+3,777.1%+108.7%+3,668.4%+2,660.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling